Impact of dialysis dependence on survival for multiple myeloma with renal impairment: a multicenter study in China

被引:0
|
作者
Jian, Yuan [1 ]
Zhou, Huixing [1 ]
Xie, Weiwei [2 ]
Ren, Yuan [3 ]
Zhang, Zhiyao [1 ]
Yang, Guangzhong [1 ]
Geng, Chuanying [1 ]
Jia, Jing [1 ]
Chen, Wenming [1 ]
Huang, Wenrong [3 ]
Cen, Xinan [2 ]
Gao, Wen [1 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Myeloma Res Ctr Beijing, Dept Hematol, Beijing, Peoples R China
[2] Peking Univ First Hosp, Dept Hematol, Beijing, Peoples R China
[3] Gen Hosp Peoples Liberat Army, Med Ctr 5, Dept Hematol, Beijing, Peoples R China
来源
AMERICAN JOURNAL OF CANCER RESEARCH | 2023年 / 13卷 / 04期
基金
北京市自然科学基金;
关键词
Multiple myeloma; renal impairment; dialysis dependence; dialysis independence; survival; DIAGNOSIS; RECOVERY; POPULATION; MORTALITY; FAILURE; OUTCOMES; THERAPY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Renal impairment (RI) is a very common complication of multiple myeloma (MM) with a negative impact on survival. Herein we retrospectively analyzed 334 MM patients with renal impairment at diagnosis from three hospi-tals in China. All 334 patients were divided into three groups, including dialysis dependence (n=43), dialysis inde-pendence (n=42), and without dialysis (n=249). Compared with dialysis independence and without dialysis groups, dialysis dependence group had the lowest overall hematologic response (48.8% vs. 97.6% vs. 77.1%, P<0.001) and overall renal response (0.0% vs. 97.6% vs. 72.7%, P<0.001), as well as the highest early mortality within 24 months (50.0% vs. 24.4% vs. 26.3%, P=0.006). Dialysis dependence group had similar progression-free survival (24 vs. 26 vs. 27 months, P=0.231) and significantly shorter overall survival (25 vs. 69 vs. 45 months, P=0.001). Dialysis dependence was independently associated with high mortality within 24 months and shorter overall survival. In conclusion, MM patients with dialysis dependence still tend to suffer a dismal disease course, including a high probability to suffer early mortality, worse hematological and renal response, as well as shorter survival. Dialysis independence could be very promising for survival improvement.
引用
收藏
页码:1571 / 1581
页数:11
相关论文
共 50 条
  • [41] Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis
    Decourt, Alexandre
    Gondouin, Bertrand
    Delaroziere, Jean Christophe
    Brunet, Philippe
    Sallee, Marion
    Burtey, Stephane
    Dussol, Bertrand
    Ivanov, Vadim
    Costello, Regis
    Couchoud, Cecile
    Jourde-Chiche, Noemie
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (03): : 431 - 441
  • [42] Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
    Gonsalves, W. I.
    Leung, N.
    Rajkumar, S. V.
    Dispenzieri, A.
    Lacy, M. Q.
    Hayman, S. R.
    Buadi, F. K.
    Dingli, D.
    Kapoor, P.
    Go, R. S.
    Lin, Y.
    Russell, S. J.
    Lust, J. A.
    Zeldenrust, S.
    Kyle, R. A.
    Gertz, M. A.
    Kumar, S. K.
    BLOOD CANCER JOURNAL, 2015, 5 : e296 - e296
  • [43] Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
    W I Gonsalves
    N Leung
    S V Rajkumar
    A Dispenzieri
    M Q Lacy
    S R Hayman
    F K Buadi
    D Dingli
    P Kapoor
    R S Go
    Y Lin
    S J Russell
    J A Lust
    S Zeldenrust
    R A Kyle
    M A Gertz
    S K Kumar
    Blood Cancer Journal, 2015, 5 : e296 - e296
  • [44] Improvement in Renal Function and Its Impact on Survival in Patients with Newly Diagnosed Multiple Myeloma
    Gonsalves, Wilson I.
    Leung, Nelson
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    Buadi, Francis
    Lacy, Martha Q.
    Dingli, David
    Kapoor, Prashant
    Go, Ronald S.
    Lust, John A.
    Hayman, Suzanne R.
    Lin, Yi
    Zeldenrust, Steven R.
    Kyle, Robert A.
    Gertz, Morie A.
    Kumar, Shaji
    BLOOD, 2014, 124 (21)
  • [45] MULTIPLE-MYELOMA WITH RENAL-FAILURE TREATED BY DIALYSIS
    VIALTEL, P
    ELSENER, M
    MALLARET, MR
    ROUGIER, D
    MICHALLET, M
    DECHELETTE, E
    DENIS, MC
    CORDONNIER, D
    LYON MEDICAL, 1980, 244 (16): : 213 - 217
  • [46] THE IMPACT OF FRONTLINE TREATMENT ON SURVIVAL OUTCOMES IN MULTIPLE MYELOMA (RETROSPECTIVE STUDY)
    Ionita, I.
    Iordache, M.
    Ionita, C. O.
    Calamar, D.
    Cioaca, R. G.
    Ionita, M.
    Pascalau, A.
    Ionita, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 583 - 584
  • [47] Factors Associated with Renal Impairment at Diagnosis in Multiple Myeloma with Survival Trends over Last Two Decades
    Rakshit, Sagar
    Bansal, Radhika
    Kapoor, Prashant
    Dispenzieri, Angela
    Gertz, Morie A.
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Hwa, Yi L.
    Fonder, Amie
    Hobbs, Miriam A.
    Gonsalves, Wilson I.
    Muchtar, Eli
    Dingli, David
    Kourelis, Taxiarchis
    Warsame, Rahma M.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji
    Leung, Nelson
    BLOOD, 2021, 138
  • [48] The impact of the type of hospital on survival of multiple myeloma patients: The MICORE study
    Rios, R.
    Gonzalez-Silva, M.
    Molina, E.
    Garcia-Fernandez, J. R.
    Clavero, M. E.
    Duran, J. M.
    Lopez-Berenguel, F.
    Romero, M. M.
    Jimenez-Moleon, J. J.
    Sanchez, M. J.
    Sainz, J.
    Jurado, M.
    REVISTA CLINICA ESPANOLA, 2013, 213 (07): : 330 - 335
  • [49] Evolution of the management of multiple myeloma in a district general hospital setting; a retrospective review of renal impairment and survival
    Fleming, C.
    Babb, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 68 - 68
  • [50] Renal Response of Pomalidomide with Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study
    Jian, Yuan
    Chang, Long
    Shi, Mingxia
    Sun, Ying
    Chu, Xiaoxia
    Xue, Hua
    Huang, Wenrong
    Shen, Xuliang
    Ma, Jie
    Jia, Guorong
    Peng, Yaqing
    Xi, Zhenfang
    Zhao, Yanhong
    Ma, Yanping
    Xiao, Jing
    Ma, Guangyu
    Wang, Qingming
    Bao, Li
    Dong, Yujun
    Zhou, Hebing
    Sun, Chunyan
    Su, Guohong
    Yan, Yan
    Qimuge, Saiyin
    Su, Liping
    Sun, Jingnan
    Tian, Weiwei
    Sun, Xiuli
    Jing, Hongmei
    Gao, Da
    Chen, Wenming
    Li, Jian
    Gao, Wen
    BLOOD, 2022, 140 : 10167 - 10169